E
Ascendant Resources Inc. ASND.TO
TSX
Recommendation
Sell
Prev Close
$0.05
Volume
--
Avg Vol (90D)
59,297
Market Cap
$8.00M
Dividend & Yield
--
52-Week Range
$0.03 - $0.075
P/E (TTM)
--
EPS (TTM)
-$0.1782
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
E+
Very Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Very Weak
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Candriam S.C.A. Has $38.57 Million Holdings in Ascendis Pharma A/S (NASDAQ:ASND)
3/6/2025 - Ticker Report
Ascendis Pharma A/S (ASND, $151.93) RSI Indicator left the overbought zone on March 03, 2025
3/4/2025 - Tickeron - Stocks
Ascendis Pharma A/S (NASDAQ:ASND) Sets New 1-Year High - Here's Why
3/2/2025 - MarketBeat
Ascendis Pharma A/S (NASDAQ:ASND) Position Reduced by Henry James International Management Inc.
3/1/2025 - Ticker Report
Ascendis Pharma A/S (NASDAQ:ASND) Given Average Rating of "Moderate Buy" by Analysts
2/28/2025 - MarketBeat
Ascendis Pharma A/S (NASDAQ:ASND) Shares Sold by Handelsbanken Fonder AB
2/26/2025 - MarketBeat
Cantor Fitzgerald Forecasts Strong Price Appreciation for Ascendis Pharma A/S (NASDAQ:ASND) Stock
2/25/2025 - Ticker Report
Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $200.00 at Cantor Fitzgerald
2/25/2025 - MarketBeat
Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care Conference
2/24/2025 - Globe Newswire
New York State Common Retirement Fund Acquires 25,164 Shares of Ascendis Pharma A/S (NASDAQ:ASND)
2/21/2025 - MarketBeat
Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $260.00 at Evercore ISI
2/19/2025 - MarketBeat
Ascendis Pharma A/S (NASDAQ:ASND) Given New $260.00 Price Target at Evercore ISI
2/18/2025 - Ticker Report
Rice Hall James & Associates LLC Has $22.56 Million Stock Holdings in Ascendis Pharma A/S (NASDAQ:ASND)
2/18/2025 - MarketBeat
Q1 EPS Estimates for Ascendis Pharma A/S Lowered by Wedbush
2/17/2025 - MarketBeat
Ascendis Pharma A/S (NASDAQ:ASND) Yearly Results: Here's What Analysts Are Forecasting For This Year
2/15/2025 - Simply Wall St
Ascendis Pharma A/S (ASND, $144.08) Stochastic Oscillator left the overbought zone on February 14, 2025
2/15/2025 - Tickeron - Stocks
Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $225.00 at The Goldman Sachs Group
2/14/2025 - MarketBeat
Ascendis Pharma A/S (NASDAQ:ASND) Given New $168.00 Price Target at JPMorgan Chase & Co.
2/14/2025 - MarketBeat
Ascendis Pharma A/S (NASDAQ:ASND) Shares Gap Up on Better-Than-Expected Earnings
2/14/2025 - MarketBeat
Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $168.00
2/14/2025 - Ticker Report
Ascendis Pharma A/S (ASND, $142.49) price moved above its 50-day Moving Average on February 13, 2025
2/14/2025 - Tickeron - Stocks
Ascendis Pharma A/S (ASND, $142.49) Moving Average Convergence Divergence (MACD) Histogram turned positive on February 13, 2025
2/14/2025 - Tickeron - Stocks
Ascendis Pharma A/S (ASND, $142.49) Stochastic Oscillator left the oversold zone on February 13, 2025
2/14/2025 - Tickeron - Stocks
Q4 2024 Ascendis Pharma A/S Earnings Call Transcript
2/14/2025 - GuruFocus
Ascendis Pharma A/S (NASDAQ:ASND) Posts Earnings Results, Beats Estimates By $0.64 EPS
2/13/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$2.54M
EBIT (TTM)
-$2.58M
Net Income (TTM)
-$26.24M
Balance Sheet
Total Assets (Q)
$17.17M
Total Debt (Q)
$23.06M
Total Liabilities (Q)
$34.04M
Book Value Per Share (Q)
-$0.1093
Cash Flow
Cash from Operations (TTM)
-$2.36M
Cash from Investing (TTM)
-$2.81M
Cash from Financing (TTM)
$6.35M
Net Change in Cash (TTM)
$101.00K
Filings
Filing Date
Wednesday, November 13, 2024
Period Date
Monday, September 30, 2024
Next Filing
Beginning of April (est)
Price History
Loading...
Beta
-0.56
7-Day Total Return
0.00%
30-Day Total Return
-16.67%
60-Day Total Return
25.00%
90-Day Total Return
0.00%
Year to Date Total Return
0.00%
1-Year Total Return
-23.08%
2-Year Total Return
-79.17%
3-Year Total Return
-75.00%
5-Year Total Return
-76.19%
52-week Low
Sep 11, 2024 - $0.03
52-week High
Apr 02, 2024 - $0.075
Valuation
Market Cap
$8.00M - Nano Cap
Enterprise Value
$32.48M
Price/Sales (TTM)
--
Price/Book (Q)
-0.46
Dividends and Shares
Shares Outstanding
186.64M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.ascendantresources.com
Phone Number
647 805 5662
Address
200 Bay Street
Toronto, ON M5J 2J2
Country
Canada
Year Founded
2006
Business Description
Sector
Materials
Industry
Materials
Ascendant Resources Inc. explores and develops mineral properties in Portugal. The company explores for silver, gold, zinc, copper, lead, and tin. It holds 80% interest in the Lagoa Salgada... more
Weiss Ratings